These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28767065)

  • 21. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
    Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW
    Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A sensitive assay for the evaluation of cytotoxicity and its pharmacologic modulation in human solid tumor-derived cell lines exposed to cancer-therapeutic agents.
    Mirzayans R; Andrais B; Scott A; Tessier A; Murray D
    J Pharm Pharm Sci; 2007; 10(2):298s-311s. PubMed ID: 17718933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-dimensional culture system as a model for studying cancer cell invasion capacity and anticancer drug sensitivity.
    Doillon CJ; Gagnon E; Paradis R; Koutsilieris M
    Anticancer Res; 2004; 24(4):2169-77. PubMed ID: 15330157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in estimates of cisplatin-induced cell kill in vitro between colorimetric and cell count/colony assays.
    Henriksson E; Kjellén E; Wahlberg P; Wennerberg J; Kjellström JH
    In Vitro Cell Dev Biol Anim; 2006; 42(10):320-3. PubMed ID: 17316066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screen anticancer drug in vitro using resonance light scattering technique.
    Chen Z; Liu G; Chen M; Xu B; Peng Y; Chen M; Wu M
    Talanta; 2009 Feb; 77(4):1365-9. PubMed ID: 19084650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-106b-5p regulates cisplatin chemosensitivity by targeting polycystic kidney disease-2 in non-small-cell lung cancer.
    Yu S; Qin X; Chen T; Zhou L; Xu X; Feng J
    Anticancer Drugs; 2017 Sep; 28(8):852-860. PubMed ID: 28723865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.
    Ganjavi H; Gee M; Narendran A; Freedman MH; Malkin D
    Cancer Gene Ther; 2005 Apr; 12(4):397-406. PubMed ID: 15618970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
    Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
    Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of increased 64Cu uptake by human copper transporter 1 gene overexpression using PET with 64CuCl2 in human breast cancer xenograft model.
    Kim KI; Jang SJ; Park JH; Lee YJ; Lee TS; Woo KS; Park H; Choe JG; An GI; Kang JH
    J Nucl Med; 2014 Oct; 55(10):1692-8. PubMed ID: 25091475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiwell capillarity-based microfluidic device for the study of 3D tumour tissue-2D endothelium interactions and drug screening in co-culture models.
    Virumbrales-Muñoz M; Ayuso JM; Olave M; Monge R; de Miguel D; Martínez-Lostao L; Le Gac S; Doblare M; Ochoa I; Fernandez LJ
    Sci Rep; 2017 Sep; 7(1):11998. PubMed ID: 28931839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The MTT assay yields a relatively lower result of growth inhibition than the ATP assay depending on the chemotherapeutic drugs tested.
    Ulukaya E; Ozdikicioglu F; Oral AY; Demirci M
    Toxicol In Vitro; 2008 Feb; 22(1):232-9. PubMed ID: 17904330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of primary cancer cell culture models on the results of drug chemosensitivity assays: the application of perfusion microbioreactor system as cell culture vessel.
    Hsieh CH; Chen YD; Huang SF; Wang HM; Wu MH
    Biomed Res Int; 2015; 2015():470283. PubMed ID: 25654105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug effects analysis on cells using a high throughput microfluidic chip.
    Gong Z; Zhao H; Zhang T; Nie F; Pathak P; Cui K; Wang Z; Wong S; Que L
    Biomed Microdevices; 2011 Feb; 13(1):215-9. PubMed ID: 20978852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cisplatin and photodynamic therapy exert synergistic inhibitory effects on small-cell lung cancer cell viability and xenograft tumor growth.
    Cheng YS; Peng YB; Yao M; Teng JP; Ni D; Zhu ZJ; Zhuang BF; Yang ZY
    Biochem Biophys Res Commun; 2017 Jun; 487(3):567-572. PubMed ID: 28431928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A flavonoid isolated from Streptomyces sp. (ERINLG-4) induces apoptosis in human lung cancer A549 cells through p53 and cytochrome c release caspase dependant pathway.
    Balachandran C; Sangeetha B; Duraipandiyan V; Raj MK; Ignacimuthu S; Al-Dhabi NA; Balakrishna K; Parthasarathy K; Arulmozhi NM; Arasu MV
    Chem Biol Interact; 2014 Dec; 224():24-35. PubMed ID: 25289772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro antiproliferative and apoptosis-inducing properties of a mononuclear copper(II) complex with dppz ligand, in two genotypically different breast cancer cell lines.
    Dhivya R; Jaividhya P; Riyasdeen A; Palaniandavar M; Mathan G; Akbarsha MA
    Biometals; 2015 Oct; 28(5):929-43. PubMed ID: 26335033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells.
    Czarnomysy R; Surażyński A; Popławska B; Rysiak E; Pawłowska N; Czajkowska A; Bielawski K; Bielawska A
    Mol Cell Biochem; 2017 Mar; 427(1-2):13-22. PubMed ID: 27995416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
    Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
    Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of wild-type p53 gene transfection on the growth and cisplatin sensitivity of cervical cancer cell line HeLa].
    Wang X; Peng Z; Wang H
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):40-2. PubMed ID: 12599424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interference by anti-cancer chemotherapeutic agents in the MTT-tumor chemosensitivity assay.
    Ulukaya E; Colakogullari M; Wood EJ
    Chemotherapy; 2004 Apr; 50(1):43-50. PubMed ID: 15084806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.